Work

Circulating tumor DNA (ctDNA) mutations associate with response in patients (pts) with extensive-stage small cell lung cancer (ES-SCLC) treated with talazoparib (TALA) and temozolomide (TMZ).

Year: 2022

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2022.40.16_suppl.8582

Authors: Maria A Velez, Amy Lauren Cummings, Matthew C Mulroy, Edward B. Garon, Dennis J. Slamon, Jonathan W. Goldman

Institutions: University of California, Los Angeles, Ronald Reagan UCLA Medical Center, UCLA Medical Center

Language: English

Topic: Lung Cancer Research Studies

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: Pfizer

OpenAlex ID: W4281695114

Cites:

Cited by:

Related to: 10